comparemela.com

The technical panel had earlier sought additional clarifications from Bharat Biotech, the manufacturer of Covaxin, in order to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of the vaccine.

Related Keywords

India ,New Delhi ,Delhi ,Bharat , ,Pfizer ,Bio Serum Institute Of India ,Astrazeneca ,Serum Institute ,Technical Advisory Group For Emergency Use Listing ,Technical Advisory Group ,World Health Organisation ,Bharat Biotech ,Emergency Use Listing ,Covaxin ,Who ,Emergency Use Authorisation ,Covid 19 ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.